Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 3 | 3 | — | — | — | 4 |
Carcinoma | D002277 | — | C80.0 | — | 2 | — | — | — | 2 |
Basal cell carcinoma | D002280 | — | — | — | 2 | — | — | — | 2 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | — | 2 | — | — | — | 2 |
Squamous cell carcinoma | D002294 | — | — | — | 2 | — | — | — | 2 |
Basal cell neoplasms | D018295 | — | — | — | 2 | — | — | — | 2 |
Leiomyosarcoma | D007890 | — | — | — | 1 | — | — | — | 1 |
Glioma | D005910 | EFO_0000520 | — | 1 | 1 | — | — | — | 1 |
Merkel cell carcinoma | D015266 | EFO_1001471 | C4A | — | 1 | — | — | — | 1 |
Squamous cell neoplasms | D018307 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Onfekafusp alfa |
INN | onfekafusp alfa |
Description | Onfekafusp alfa is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | fusion proteins |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4298007 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 6HXC0O6JMV (ChemIDplus, GSRS) |